clinical trials

News

GSK backs up its Blenrep rehab bid with survival data

GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it fail

R&D

A clearer harmony and attractiveness for EU Clinical Trials ...

EU Clinical Trials Regulation (EU CTR) has been a hot topic for a little while now.

News

4DMT gene therapy cuts need for Eylea in wet AMD trial

A mid-stage trial of 4D Molecular Therapeutics gene therapy for eye disease age-related macular degeneration (AMD) 4D-150 has shown promising signs of efficacy, plus a red

News

First patient treated with Moderna's PD-1/IDO1 cancer shot

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets th

News

Intellia’s president and chief executive John Leonard

Intellia’s CRISPR drug could offer one-shot HAE treatment

A single dose of a gene-editing drug being developed by Intellia Therapeutics almost eliminated attacks in patients with hereditary angioedema (HAE) in a clinical trial, p

News

Lundbeck study knocks confidence in alpha-syn as CNS target

A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), althou

GSK backs up its Blenrep rehab bid with survival data

A clearer harmony and attractiveness for EU Clinical Trials ...

4DMT gene therapy cuts need for Eylea in wet AMD trial

First patient treated with Moderna's PD-1/IDO1 cancer shot

Intellia’s CRISPR drug could offer one-shot HAE treatment

Lundbeck study knocks confidence in alpha-syn as CNS target

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

clinical trials

Editor's Picks